Hyperliquid Strategies, a pending merged entity involving Nasdaq-listed Sonnet BioTherapeutics and Rorschach I LLC, has filed an S-1 registration statement with the US Securities and Exchange Commission (SEC) to raise up to $1 billion.
Read MoreHyperliquid Strategies, a pending merged entity involving Nasdaq-listed Sonnet BioTherapeutics and Rorschach I LLC, has filed an S-1 registration statement with the US Securities and Exchange Commission (SEC) to raise up to $1 billion.
Read MoreOn November 10, 2025, Cboe Global Markets will introduce perpetual futures for Bitcoin and Ethereum. This is a major development in bringing crypto derivatives under U.S. regulation.
Read MoreCryptocurrency exchange OKX today introduced USDT-margined perpetual futures contracts for two AI-focused digital assets: GRIFFAIN and ZEREBRO.
Read MoreBitnomial, a crypto derivatives exchange company, has announced the upcoming launch of its Botanical platform, a U.S.-regulated perpetual futures trading platform.
Read More